AFMD
Affimed NV
NASDAQ: AFMD · HEALTHCARE · BIOTECHNOLOGY
$0.18
+0.00% today
Updated 2026-04-29
Market cap
$2.98M
P/E ratio
—
P/S ratio
0.53x
EPS (TTM)
$-5.09
Dividend yield
—
52W range
$0 – $1
Volume
23.5M
Affimed NV (AFMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+2.9%
Last 4 quarters
Revenue YoY growth
-92.1%
Most recent quarter
EPS YoY growth
-487.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-09-30 | $-0.95 | $-0.94 | +1.4% | $155000.00 | -92.1% |
| 2024-06-30 | $-0.89 | $-1.01 | -13.5% | $154000.00 | -88.9% |
| 2024-03-31 | $-1.43 | $-1.27 | +11.2% | $155000.00 | -96.6% |
| 2023-12-31 | $-1.54 | $-1.35 | +12.3% | $413000.00 | -96.3% |
| 2023-09-30 | $-0.18 | $-0.16 | +11.1% | $1.96M | -86.8% |
| 2023-06-30 | $-0.19 | $-0.20 | -5.3% | $1.39M | -81.0% |
| 2023-03-31 | $-0.20 | $-0.21 | -5.0% | $4.51M | -43.7% |
| 2022-12-31 | $-0.19 | $-0.22 | -15.8% | $11.16M | +7.9% |
| 2022-09-30 | $-0.18 | $-0.11 | +38.9% | $14.89M | — |
| 2022-06-30 | $-0.17 | $-0.13 | +23.5% | $7.30M | — |
| 2022-03-31 | $-0.18 | $-0.14 | +22.2% | $8.01M | — |
| 2021-12-31 | $-0.16 | $-0.19 | -18.8% | $10.34M | — |
Frequently asked questions
Has Affimed NV beaten earnings estimates?
Affimed NV has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +2.9% over the last 4 quarters.
What is Affimed NV's revenue growth rate?
Affimed NV reported year-over-year revenue growth of -92.1% in its most recent quarter, with EPS growing -487.5% year-over-year.